We use cookies to give you the best experience possible with our website and to improve our communication with you. We consider your selection and will only use the data you have approved us to gather.

Geistlich Derma-Gide^®

Expect Performance

In an IRB approved 10-patient retrospective study^¹, the authors assessed the clinical effectiveness and healing characteristics of the Geistlich Derma- Gide^®. Additional data was collected on the average cost to treat each patient as well as unique handling and performance characteristics of the product.

Continuous Clinical Research

Geistlich has a long history of clinical research supporting the effectiveness and performance of their products.

Ongoing research:

Randomized controlled prospective clinical study to compare Geistlich Derma-Gide^® vs Standard of Care in the treatment of Diabetic Foot Ulcers

Case Example: 4 cm² Diabetic Foot Ulcer

1/2

‹›

Patient information: 63-year-old Female with Diabetes mellitus

2 cm × 2 cm plantar Diabetic Foot Ulcer with wound edge maceration and exposed cartilage and tendon | Wagner grade 2 | 6 months of unsuccessful treatment with Standard of Care | Healing after 4 weeks of Geistlich Derma-Gide^® treatment

Case Example: 15 cm² Diabetic Foot Ulcer

2/2

‹›

Patient information: 43-year-old Male with Diabetes mellitus

5 cm × 3 cm distal Diabetic Foot Ulcer with exposed bones | Wagner grade 2 | Two months of unsuccessful treatment with Standard of Care | Significant progression/healing after 6 weeks of Geistlich Derma-Gide^® treatment

Reference:

Data on file

Downloads

Peer-Reviewed Clinical Data

Geistlich Derma-Gide®

Expect Performance

Continuous Clinical Research

Geistlich Derma-Gide^®